| Vanguard FTSE Asia Ex Japan Shares Index ETF (VAE) |
Financials |
$772 |
Exit Statement
|
29 Jul 2025 11:57AM |
$88.555 |
$100.900 |
risen by
13.94%
|
|
| Trek Metals Limited (TKM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$128 |
Investor Presentation - RRS Twilight series
|
29 Jul 2025 11:56AM |
$0.085 |
$0.205 |
risen by
141.18%
|
|
| Maronan Metals Limited (MMA) ORDINARY FULLY PAID |
Materials |
$116 |
Notification of cessation of securities - MMA
|
29 Jul 2025 11:56AM |
$0.240 |
$0.460 |
risen by
91.67%
|
|
| Australian Agricultural Projects Limited (AAP) ORDINARY FULLY PAID |
Consumer Staple |
$17 |
Quarterly Update and Appendix 4C - June 2025
|
29 Jul 2025 11:53AM |
$0.049 |
$0.047 |
fallen by
4.08%
|
|
AAP - Price-sensitive ASX Announcement
Full Release
Key Points
- AAP completed the annual olive harvest with improved yields and oil content compared to previous years.
- Rainfall and weather conditions positively influenced production outcomes during the quarter.
- Cash flow report details receipts from customers and payments for orchard and corporate expenses.
- The company maintained a focus on operational improvements and cost control measures.
- Statutory ASX disclosures and Appendix 4C are included in the report.
- Outlook discusses plans for continued productivity enhancements and financial stability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Munro Concentrated Global Growth Fund (Managed Fund) (MCGG) |
Financials |
$87 |
Monthly Portfolio Holdings - June 2025
|
29 Jul 2025 11:51AM |
$14.920 |
$14.790 |
fallen by
0.87%
|
|
| Munro Climate Change Leaders Fund (Managed Fund) (MCCL) |
Financials |
$177 |
Monthly Portfolio Holdings - June 2025
|
29 Jul 2025 11:49AM |
$17.200 |
$19.040 |
risen by
10.70%
|
|
| Carnavale Resources Limited (CAV) ORDINARY FULLY PAID |
Materials |
$59 |
Becoming a substantial holder - P Reese
|
29 Jul 2025 11:48AM |
$0.004 |
$0.145 |
risen by
3,525%
|
|
| Munro Global Growth Fund (MAET) |
Financials |
$345 |
Monthly Portfolio Holdings - June 2025
|
29 Jul 2025 11:47AM |
$6.170 |
$6.180 |
risen by
0.16%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$48 |
Amended Quarterly Activities/Appendix 4C Cash Flow
|
29 Jul 2025 11:45AM |
$0.155 |
$0.170 |
risen by
9.68%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Nova Eye Medical Limited reported quarterly activities and cash flows for the period ending 30 September 2023.
- Sales of iTrack Advance increased in the US and European markets.
- Molteno3 glaucoma drainage device sales continued to grow.
- Investments in research and development remained a focus to support commercial strategy.
- Cash at the end of the quarter was reported, with sufficient reserves for ongoing operations.
- The company highlighted ongoing regulatory and commercialization activities.
- Strategic priorities include expanding market reach and new product development.
- No significant changes to related party arrangements were reported.
- Amendments in the report relate to corrections in specific financial figures and clarifications.
- Market trends indicate sustained demand for ophthalmic medical devices, particularly for glaucoma treatment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$69 |
Notification of cessation of securities - BOL
|
29 Jul 2025 11:44AM |
$1.355 |
$1.760 |
risen by
29.89%
|
|
| EnviroSuite Limited (EVS) ORDINARY FULLY PAID |
Information Technology |
- |
Notice regarding Second Court Hearing
|
29 Jul 2025 11:43AM |
$0.087 |
$0.090 |
risen by
2.87%
|
|
| AML3D Limited (AL3) ORDINARY FULLY PAID |
Industrials |
$88 |
Exercise of Options and Cleansing Notice
|
29 Jul 2025 11:42AM |
$0.285 |
$0.160 |
fallen by
43.86%
|
|
| AML3D Limited (AL3) ORDINARY FULLY PAID |
Industrials |
$88 |
Application for quotation of securities - AL3
|
29 Jul 2025 11:41AM |
$0.285 |
$0.160 |
fallen by
43.86%
|
|
| Central Petroleum Limited (CTP) ORDINARY FULLY PAID |
Energy |
$54 |
Becoming a substantial holder
|
29 Jul 2025 11:41AM |
$0.055 |
$0.072 |
risen by
30.91%
|
|
| Spenda Limited (SPX) ORDINARY FULLY PAID |
Information Technology |
$16 |
Investor Webinar
|
29 Jul 2025 11:37AM |
$0.007 |
$0.003 |
fallen by
57.14%
|
|
| Mount Burgess Mining NL (MTB) ORDINARY FULLY PAID |
Materials |
- |
June 2025 Quarterly Activities and Cash Flow Reports
|
29 Jul 2025 11:37AM |
$0.005 |
$0.015 |
risen by
200%
|
|
MTB - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly update focuses on the Kihabe-Nxuu Zinc-Lead-Silver-Germanium-Vanadium project in Botswana.
- Significant emphasis on resource estimation and metallurgical test work.
- Exploration activities and laboratory analysis reported for both the Kihabe and Nxuu deposits.
- Administrative and corporate costs, including cash flow management, are detailed.
- Ongoing funding requirements and strategic planning for project advancement are discussed.
- Progress on project feasibility studies and development programs highlighted.
- Challenges identified include further exploration funding and technical evaluation.
- Company continues to engage with stakeholders and pursue partnerships for project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$7,220 |
Securities Trading Policy
|
29 Jul 2025 11:34AM |
$19.030 |
$25.570 |
risen by
34.37%
|
|
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$4 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 11:34AM |
$0.003 |
$0.003 |
fallen by
16.67%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 1A trial for CHM 1101 (CLTX CAR T) in glioblastoma successfully completed, meeting safety and tolerance endpoints.
- Phase 1B trial for CHM 1101 initiated, focusing on dose expansion and additional patient enrolment.
- Advancement in preclinical development for other cell therapy product candidates, including CHM 2101 and ADTC clinical programs.
- Continued manufacturing readiness, with process improvements made for clinical supply needs.
- Regulatory milestones achieved, including approvals to commence additional studies and ongoing engagement with international regulatory agencies.
- Publication of key scientific findings in peer-reviewed journals and presentations at major industry conferences.
- Strengthened collaborations with academic and clinical partners to accelerate research and trial recruitment.
- Cash flow report details operating cash outflows of approximately $3.2 million for the quarter, with a reported cash balance sufficient for ongoing operations.
- No significant revenue generated; primary expenditures related to R&D, staff costs, and administration.
- Commitment to operational efficiency and financial discipline while advancing clinical and preclinical programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQT Holdings Limited (EQT) ORDINARY FULLY PAID |
Financials |
$601 |
Details for EQT's Full Year Results release and webinar
|
29 Jul 2025 11:34AM |
$32.450 |
$22.440 |
fallen by
30.85%
|
|
| Aurora Energy Metals Limited (1AE) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2025 11:30AM |
$0.047 |
$0.100 |
risen by
112.77%
|
|
1AE - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurora Energy Metals Project (AEMP) in Oregon is the company's primary focus.
- Ongoing environmental baseline studies and permitting activities progressed during the quarter.
- Initial metallurgical testwork was conducted to support the Pre-Feasibility Study (PFS).
- Community engagement activities and stakeholder communications continued.
- Exploration and development expenditure was detailed in the Appendix 5B Cash Flow Report.
- The company maintained a stable cash position, supporting ongoing project development.
- Aurora Energy Metals Limited is targeting uranium and lithium resources.
- Key work streams for the next quarter include further PFS advancement and ongoing studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DevEx Resources Limited (DEV) ORDINARY FULLY PAID |
Materials |
$181 |
Notification regarding unquoted securities - DEV
|
29 Jul 2025 11:27AM |
$0.082 |
$0.255 |
risen by
210.98%
|
|
| Hydrocarbon Dynamics Limited (HCD) ORDINARY FULLY PAID |
Energy |
$4 |
Revised Appendix 5B
|
29 Jul 2025 11:25AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Voltaic Strategic Resources Ltd (VSR) ORDINARY FULLY PAID |
Materials |
$32 |
Becoming a substantial holder
|
29 Jul 2025 11:23AM |
$0.017 |
$0.057 |
risen by
235.29%
|
|
| N1 Holdings Limited (N1H) ORDINARY FULLY PAID |
Financials |
$9 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 11:22AM |
$0.110 |
$0.105 |
fallen by
4.55%
|
|
N1H - Price-sensitive ASX Announcement
Full Release
Key Points
- N1 Holdings Limited lodged its Quarterly Activities/Appendix 4C Cash Flow Report for the quarter ending 31 March 2024.
- The company continues to focus on mortgage management, commercial lending, and advisory services.
- Commercial lending division experienced further growth during the quarter.
- New funding arrangements were put in place to support lending activities.
- The mortgage management portfolio continued performing steadily.
- Net cash outflows from operating activities were primarily due to staff, administration, and operating expenses.
- Receipts from customers provided partial offset to operating cash outflows.
- No significant business acquisitions or disposals occurred during the quarter.
- The company reported sufficient cash reserves and does not foresee the need for additional funding in the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Epsilon Healthcare Limited (EPN) ORDINARY FULLY PAID |
Health Care |
$11 |
Strategic $6.7m Sale and Leaseback of Southport Property
|
29 Jul 2025 11:21AM |
$0.024 |
$0.028 |
risen by
16.67%
|
|
EPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Epsilon Healthcare completed a $6.7 million sale and leaseback of its Southport property.
- The transaction aims to strengthen EPN's balance sheet by reducing debt.
- The property is sold to an independent Brisbane-based real estate investor.
- Epsilon Healthcare secured a long-term lease for continued site operations.
- The deal enhances EPN's financial flexibility and supports long-term growth strategies.
- The transaction was completed without needing further regulatory or shareholder approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.